NCT00206544View on ClinicalTrials.gov

Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Bipolar DisorderManiaSchizoaffective Disorder
Interventions
DRUG

Tamoxifen

40 mg daily of adjunctive tamoxifen in oral capsule

DRUG

Progesterone

20 mg daily of adjunctive progesterone in oral capsule

OTHER

placebo

adjunctive placebo daily in oral capsule

Trial Locations (1)

3004

Bayside Health - The Alfred Hospital, Melbourne

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

collaborator

National Health and Medical Research Council, Australia

OTHER

lead

The Alfred

OTHER

NCT00206544 - Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women? | Biotech Hunter | Biotech Hunter